Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 25, 2026
TickeronGET DAILY SIGNALS
Streamex Corp. (STEX) Shares Decline -47% Over 30 Days Amid Persistent Pressure

Streamex Corp. (STEX) Shares Decline -47% Over 30 Days Amid Persistent Pressure

Key Takeaways

  • Streamex Corp. (STEX) shares fell roughly 47% over the 30 days through the latest close, extending a sustained multi-month decline.
  • The move reflects persistent selling pressure tied to a small revenue base, recurring losses, and dilution and going-concern concerns disclosed in company filings.
  • Over the most recent quarter, the stock declined approximately 42%, continuing a downtrend from its 52-week high.
  • Streamex is pivoting toward tokenized real-world assets, anchored by its gold-backed, yield-bearing GLDY product, alongside its legacy cardiac-signal platform.
  • Operational milestones such as institutional allocations, new custody arrangements, and investor conference appearances have not yet stabilized the share price.
  • For deeper detail on valuation and expectations, explore Price Targets, Earnings, and Forecast pages.
  • Discover automated trading strategies across thousands of tickers on the Trending AI Robots page.

Company Background for Streamex Corp. (STEX)

Streamex Corp. is a technology and digital-asset infrastructure company focused on the tokenization and digitalization of real-world assets. Formerly known as BioSig Technologies, the company rebranded in September 2025 as it repositioned around bringing traditional commodities on-chain through regulated, yield-bearing financial instruments. Its flagship offering, GLDY, provides exposure to physical gold through a liquid structure that incorporates a yield component. The company also maintains its legacy PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures. Headquartered in Winter Park, Florida, STEX trades on the Nasdaq Capital Market and is closely watched by investors as a small-cap, early-stage play on the intersection of commodities, tokenization, and digital-asset infrastructure. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

STEX Stock Price Performance: Last 30 Days vs. Quarter

Over the 30 days ending at the latest close, Streamex shares declined approximately 47%, falling from a close of about $0.83 in late September to roughly $0.44. The downtrend was broadly consistent rather than a single-event collapse, with the stock grinding lower through most of October before a sharp single-session rebound late in the period partially offset the decline. On a quarterly basis, the stock declined approximately 42%, down from roughly $0.76 three months earlier. This places STEX firmly in a sustained downtrend, with the recent bounce still leaving the shares well below their levels at the start of both the month and the quarter.

What Drove STEX Stock Price in the Last 30 Days

The 30-day decline was driven primarily by sustained selling pressure rather than a single isolated catalyst. Streamex remains a micro-cap company with a limited revenue base and recurring operating losses, and its own filings have flagged uncertainty regarding liquidity and substantial doubt about its ability to continue as a going concern. These disclosures have weighed on investor confidence and contributed to persistent downward momentum in the shares. The stock's elevated volatility, reflected in a beta above 2.0, also amplified price swings in both directions during the period.

Positive operational developments during the window included the announcement of an institutional investment into a strategy built around GLDY, the availability of GLDY shares for custody through CNB Custody, participation in investor conferences, and a monthly yield distribution for the GLDY product. Despite these milestones, they were not sufficient to reverse the broader selling trend, underscoring how dilution concerns and execution uncertainty continued to dominate sentiment.

What Drove STEX Stock Performance Over the Last Quarter

Over the last quarter, Streamex's shares extended a longer-term decline that began well before the most recent 30-day window. The company reported its second-quarter 2026 results in mid-August, disclosing its first revenue from the tokenized gold platform alongside reduced expenses and a narrower net loss. However, the scale of that revenue remains modest, and the company continues to generate substantial net losses. Separately, analyst sentiment cooled as Needham lowered its price target on Streamex from $8 to $4 while maintaining a Buy rating, citing limited incremental adoption of the flagship GLDY product. The broader narrative has been shaped by the gap between an ambitious tokenization roadmap—including the planned GLDC launch and expansion into additional commodities—and the near-term financial reality of a small revenue base and ongoing financing needs.

STEX Stock Forecast Drivers: What Investors Should Watch Next

Investors monitoring Streamex should watch several factors that could shape the stock's trajectory. The pace of adoption and assets under management for the GLDY product remain central, as does the planned launch of GLDC and any expansion into additional commodities. Financing activity and its dilutive impact are a key risk, given the company's disclosures around liquidity and going-concern uncertainty. Further institutional allocations, custody partnerships, and any progress toward recurring issuance and trading fees will be closely scrutinized. Macro conditions—particularly gold prices and broader risk appetite for small-cap and digital-asset names—also have the potential to influence sentiment. As with all early-stage, high-volatility equities, investors should weigh these factors carefully rather than relying on short-term price moves. From what I see, this is important because near-term execution will likely determine whether sentiment can shift.

Exploring AI Trading Bots for Systematic Strategies

In my own research process, I have found value in reviewing systematic approaches alongside fundamental analysis. Tickeron's AI Trading Bots offer a range of automated strategies that can complement manual review of names like STEX, helping to surface data-driven signals across different timeframes and market conditions.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: STEX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


STEX's RSI Oscillator recovers from oversold territory

The RSI Oscillator for STEX moved out of oversold territory on November 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 47 similar instances when the indicator left oversold territory. In 44 of the 47 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 54 of 63 cases where STEX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Moving Average Convergence Divergence (MACD) for STEX just turned positive on October 26, 2026. Looking at past instances where STEX's MACD turned positive, the stock continued to rise in 41 of 48 cases over the following month. The odds of a continued upward trend are 85%.

Following a +13.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where STEX advanced for three days, in 216 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on STEX as a result. In 72 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where STEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for STEX entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. STEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.271) is normal, around the industry mean (3.143). P/E Ratio (-0.038) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.975) among similar stocks. STEX's P/S Ratio (526.316) is very high in comparison to the industry average of (17.075).

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. STEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 11.61B. The market cap for tickers in the group ranges from 590 to 284.96B. MS holds the highest valuation in this group at 284.96B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -14%. For the same Industry, the average monthly price growth was -26%, and the average quarterly price growth was -34%. NCPL experienced the highest price growth at 67%, while LGHL experienced the biggest fall at -51%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 64%. For the same stocks of the Industry, the average monthly volume growth was 51% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 66
Price Growth Rating: 72
SMR Rating: 74
Profit Risk Rating: 89
Seasonality Score: 0 (-100 ... +100)
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a development stage company which develops medical devices

Industry InvestmentBanksBrokers

Industry
Medical Specialties
Address
2431 Aloma Avenue
Phone
+1 203 409-5444
Employees
6
Web
https://www.streamex.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.